Skip to content
Tel 631.240.8800| Fax 631.240.8900|Contact Us|info@adnas.com
YouTubeXLinkedInVimeo
Applied DNA Sciences Logo
  • Company Info
    • About Us
    • Management Team
      • Board of Directors
    • Careers
    • Quality Policy
    • Partners and Customers
  • Business Segments
    • Therapeutic DNA Production
    • Enterprise-Scale Diagnostic Testing Solutions
      • TR8™PGx Pharmacogenomic Testing
    • DNA Tagging and Security Products and Services
  • News
    • Press Releases
    • APDN in the News
    • Blog: Keeping Life Real and Safe
    • Applied DNA Upcoming Events
  • Investor Relations
ADNAS Blogheather2016-06-28T12:40:52-04:00

Recent Posts

  • Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
  • Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
  • ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-cell Therapy Produced from LineaDNA
  • Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
  • Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Get Social

Recent Tweets

Tweets by

COMPANY LINKS

  • About Us
  • Press Releases
  • Company News
  • Careers

POLICIES AND TERMS

  • Privacy Policy
  • Terms of Use
  • Terms and Conditions of Sale
  • Quality Policy
  • Cookies
  • Accessibility
  • Authentication Terms and Conditions of Service

FOLLOW US

Page load link
We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.AcceptPrivacy policy
Go to Top